{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:18:26Z","timestamp":1788002306386,"version":"build-2784847793"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000737","name":"University of Exeter","doi-asserted-by":"publisher","award":["NIHR Grant\/Award Number NIHR203320"],"award-info":[{"award-number":["NIHR Grant\/Award Number NIHR203320"]}],"id":[{"id":"10.13039\/501100000737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000275","name":"Leverhulme Trust","doi-asserted-by":"publisher","award":["RPG-2021-152"],"award-info":[{"award-number":["RPG-2021-152"]}],"id":[{"id":"10.13039\/501100000275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Genetic counselling for hereditary cancer predisposition has evolved substantially over more than three decades, driven by advances in genomic technologies and the growing use of tumour and germline testing. These developments have expanded access to hereditary cancer testing, treatment and prevention, while also introducing new clinical, psychosocial and system-level challenges. This review examines the transition from traditional specialist-led genetic counselling to mainstreamed testing pathways. Using Lynch syndrome as a paradigm, we explore how service redesign, personalised risk communication and patient experience intersect in contemporary hereditary cancer care. This invited review synthesises clinical, academic and patient perspectives on the evolution of hereditary cancer genetic counselling. Lived experiences of Lynch syndrome were incorporated through patient and public involvement contributors involved in manuscript development and interpretation. Mainstreamed testing has expanded access to genomic information and strengthened opportunities for cascade testing and prevention within families. However, it has also increased testing volumes, complexity of results interpretation and reliance on non-genetics clinicians. As a result, effective care requires close coordination between genetics and cancer services, alongside support for shared decision-making, family communication and psychosocial needs. This review uniquely integrates clinical evidence and lived experience to highlight how mainstreaming has transformed the delivery of hereditary cancer genetic counselling but not the need for specialist genetics expertise. Lynch syndrome illustrates how genomics can be integrated into routine cancer care while maintaining personalised counselling and family-centred follow-up. These principles are relevant across hereditary cancer predispositions and inform the future development of genetic counselling services.<\/jats:p>","DOI":"10.1007\/s10689-026-00597-6","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:02:40Z","timestamp":1787997760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The evolution of hereditary cancer genetic counselling: mainstreaming, service redesign and patient experience in Lynch syndrome"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9852-2872","authenticated-orcid":false,"given":"Kelly","family":"Kohut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alekhya","family":"Ashokan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Vicari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Ditchfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Bux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Lalloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"issue":"2","key":"597_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10897-005-9014-3","volume":"15","author":"R Resta","year":"2006","unstructured":"Resta R et al (2006) A new definition of genetic counseling: National Society of Genetic Counselors\u2019 Task Force report. J Genet Couns 15(2):77\u201383","journal-title":"J Genet Couns"},{"key":"597_CR2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038968","author":"B Biesecker","year":"2020","unstructured":"Biesecker B (2020) Genetic counseling and the central tenets of practice. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a038968","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"597_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/medhum-2022-012472","volume":"49","author":"J Bangham","year":"2023","unstructured":"Bangham J (2023) Making the \u201cgenetic counsellor\u201d in the UK, 1980\u20131995. Med Humanit 49(2):248\u2013259","journal-title":"Med Humanit"},{"issue":"5182","key":"597_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66\u201371","journal-title":"Science"},{"issue":"6559","key":"597_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789\u2013792","journal-title":"Nature"},{"issue":"1","key":"597_CR6","first-page":"1","volume":"77","author":"R Fishel","year":"1994","unstructured":"Fishel R et al (1994) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 77(1):1","journal-title":"Cell"},{"issue":"6468","key":"597_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/368258a0","volume":"368","author":"CE Bronner","year":"1994","unstructured":"Bronner CE et al (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368(6468):258\u2013261","journal-title":"Nature"},{"issue":"20","key":"597_CR8","first-page":"5068","volume":"59","author":"RD Kolodner","year":"1999","unstructured":"Kolodner RD et al (1999) Germ-line msh6 mutations in colorectal cancer families. Cancer Res 59(20):5068\u20135074","journal-title":"Cancer Res"},{"issue":"6492","key":"597_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/371075a0","volume":"371","author":"NC Nicolaides","year":"1994","unstructured":"Nicolaides NC et al (1994) Mutations of two P\/WS homologues in hereditary nonpolyposis colon cancer. Nature 371(6492):75\u201380","journal-title":"Nature"},{"issue":"1","key":"597_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jmoldx.2010.11.011","volume":"13","author":"K Rumilla","year":"2011","unstructured":"Rumilla K et al (2011) Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. J Mol Diagn 13(1):93\u201399","journal-title":"J Mol Diagn"},{"key":"597_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fonc.2016.00120","volume":"6","author":"AH Buchanan","year":"2016","unstructured":"Buchanan AH, Rahm AK, Williams JL (2016) Alternate service delivery models in cancer genetic counseling: a mini-review. Front Oncol 6:120","journal-title":"Front Oncol"},{"key":"597_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036541","author":"J Schienda","year":"2020","unstructured":"Schienda J, Stopfer J (2020) Cancer genetic counseling-current practice and future challenges. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a036541","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"11","key":"597_CR13","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41431-024-01552-8","volume":"32","author":"M Paneque","year":"2024","unstructured":"Paneque M et al (2024) Thirty-years of genetic counselling education in Europe: a growing professional area. Eur J Hum Genet 32(11):1500\u20131505","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"597_CR14","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/eurpub\/ckae093","volume":"34","author":"JM McCrary","year":"2024","unstructured":"McCrary JM et al (2024) Genetic counselling legislation and practice in cancer in EU Member States. Eur J Public Health 34(4):666\u2013675","journal-title":"Eur J Public Health"},{"issue":"4","key":"597_CR15","first-page":"273","volume":"19","author":"J Barwell","year":"2019","unstructured":"Barwell J, Snape K, Wedderburn S (2019) The new genomic medicine service and implications for patients. Clin Med (Lond) 19(4):273\u2013277","journal-title":"Clin Med (Lond)"},{"key":"597_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2025.101465","author":"MP Mackley","year":"2025","unstructured":"Mackley MP et al (2025) Mainstreaming of clinical genetic testing: a conceptual framework. Genet Med. https:\/\/doi.org\/10.1016\/j.gim.2025.101465","journal-title":"Genet Med"},{"issue":"8","key":"597_CR17","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","volume":"30","author":"C Luchini","year":"2019","unstructured":"Luchini C et al (2019) ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach. Ann Oncol 30(8):1232\u20131243","journal-title":"Ann Oncol"},{"issue":"7","key":"597_CR18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.6004\/jnccn.2021.7044","volume":"19","author":"YL Liu","year":"2021","unstructured":"Liu YL, Stadler ZK (2021) The future of parallel tumor and germline genetic testing: is there a role for all patients with cancer? J Natl Compr Canc Netw 19(7):871\u2013878","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"597_CR19","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/annonc\/mdz136","volume":"30","author":"D Mandelker","year":"2019","unstructured":"Mandelker D et al (2019) Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group. Ann Oncol 30(8):1221\u20131231","journal-title":"Ann Oncol"},{"key":"597_CR20","doi-asserted-by":"crossref","unstructured":"Ponti G et al. (2025) Hereditary Micro\u2011Satellite Instable cancers associated with Lynch Syndrome: predictive biomarkers and novel immuno-therapeutic approaches. Crit Rev Clin Lab Sci 1\u201314","DOI":"10.1080\/10408363.2025.2504915"},{"issue":"1","key":"597_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/10600280211013489","volume":"56","author":"M Kaneko","year":"2022","unstructured":"Kaneko M (2022) Effect of PARP inhibitors as maintenance treatment on restricted mean survival time in platinum-sensitive recurrent ovarian cancer: a systematic review and meta-analysis. Ann Pharmacother 56(1):27\u201334","journal-title":"Ann Pharmacother"},{"issue":"9","key":"597_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.31427","volume":"7","author":"Z Rezoug","year":"2024","unstructured":"Rezoug Z et al (2024) Universal genetic testing for newly diagnosed invasive breast cancer. JAMA Netw Open 7(9):e2431427","journal-title":"JAMA Netw Open"},{"issue":"8","key":"597_CR23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12032-025-02849-4","volume":"42","author":"GTM do Nascimento","year":"2025","unstructured":"do Nascimento GTM et al (2025) Can Pembrolizumab or Nivolumab be efficiently used against colorectal cancers with defective mismatch repair and high index of microsatellite instability? Med Oncol 42(8):306","journal-title":"Med Oncol"},{"key":"597_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16050849","author":"A Dal Buono","year":"2024","unstructured":"Dal Buono A et al (2024) Lynch syndrome: from multidisciplinary management to precision prevention. Cancers. https:\/\/doi.org\/10.3390\/cancers16050849","journal-title":"Cancers"},{"key":"597_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cancergen.2022.02.010","volume":"264\u2013265","author":"K Barrus","year":"2022","unstructured":"Barrus K et al (2022) Somatic tumor testing implications for Lynch syndrome germline genetic testing. Cancer Genet 264\u2013265:16\u201322","journal-title":"Cancer Genet"},{"key":"597_CR26","doi-asserted-by":"publisher","first-page":"1125599","DOI":"10.3389\/fgene.2023.1125599","volume":"14","author":"C Carpenter-Clawson","year":"2023","unstructured":"Carpenter-Clawson C et al (2023) Competencies of the UK nursing and midwifery workforce to mainstream genomics in the National Health Service: the ongoing gap between perceived importance and confidence in genomics. Front Genet 14:1125599","journal-title":"Front Genet"},{"issue":"1","key":"597_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-025-02081-y","volume":"27","author":"CL Jong","year":"2025","unstructured":"Jong CL et al (2025) The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMART study. Breast Cancer Res 27(1):129","journal-title":"Breast Cancer Res"},{"issue":"7","key":"597_CR28","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41436-020-0785-6","volume":"22","author":"S White","year":"2020","unstructured":"White S, Jacobs C, Phillips J (2020) Mainstreaming genetics and genomics: a systematic review of the barriers and facilitators for nurses and physicians in secondary and tertiary care. Genet Med 22(7):1149\u20131155","journal-title":"Genet Med"},{"key":"597_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep29506","volume":"6","author":"A George","year":"2016","unstructured":"George A et al (2016) Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients. Sci Rep 6:29506","journal-title":"Sci Rep"},{"issue":"10","key":"597_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.6004\/jnccn.2024.0061","volume":"22","author":"R Hodan","year":"2024","unstructured":"Hodan R et al (2024) Genetic\/familial high-risk assessment: colorectal, endometrial, and gastric, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 22(10):695\u2013711","journal-title":"J Natl Compr Canc Netw"},{"issue":"Supplement","key":"597_CR31","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2025.5010","volume":"23","author":"KN Maxwell","year":"2025","unstructured":"Maxwell KN et al (2025) Expansion of recommendations for hereditary cancers. J Natl Compr Canc Netw 23(Supplement):e255010","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"597_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13053-021-00188-9","volume":"19","author":"JB Ritchie","year":"2021","unstructured":"Ritchie JB et al (2021) Evaluation and comparison of hereditary cancer guidelines in the population. Hered Cancer Clin Pract 19(1):31","journal-title":"Hered Cancer Clin Pract"},{"issue":"4","key":"597_CR33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41436-020-01029-1","volume":"23","author":"M Dominguez-Valentin","year":"2021","unstructured":"Dominguez-Valentin M et al (2021) Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report. Genet Med 23(4):705\u2013712","journal-title":"Genet Med"},{"issue":"1","key":"597_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/tog.12706","volume":"23","author":"NAJ Ryan","year":"2021","unstructured":"Ryan NAJ et al (2021) Lynch syndrome for the gynaecologist. Obstet Gynaecol 23(1):9\u201320","journal-title":"Obstet Gynaecol"},{"issue":"10","key":"597_CR35","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/s41436-019-0489-y","volume":"21","author":"EJ Crosbie","year":"2019","unstructured":"Crosbie EJ et al (2019) The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. Genet Med 21(10):2390\u20132400","journal-title":"Genet Med"},{"issue":"5","key":"597_CR36","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s10897-017-0089-4","volume":"26","author":"G Joseph","year":"2017","unstructured":"Joseph G et al (2017) Information mismatch: cancer risk counseling with diverse underserved patients. J Genet Couns 26(5):1090\u20131104","journal-title":"J Genet Couns"},{"issue":"1","key":"597_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12687-020-00497-x","volume":"12","author":"J van der Giessen","year":"2021","unstructured":"van der Giessen J et al (2021) Communication about breast cancer genetic counseling with patients with limited health literacy or a migrant background: evaluation of a training program for healthcare professionals. J Community Genet 12(1):91\u201399","journal-title":"J Community Genet"},{"issue":"2","key":"597_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/jme.29.2.74","volume":"29","author":"N Hallowell","year":"2003","unstructured":"Hallowell N et al (2003) Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information. J Med Ethics 29(2):74\u201379","journal-title":"J Med Ethics"},{"issue":"6","key":"597_CR39","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s10897-014-9728-1","volume":"23","author":"J Austin","year":"2014","unstructured":"Austin J, Semaka A, Hadjipavlou G (2014) Conceptualizing genetic counseling as psychotherapy in the era of genomic medicine. J Genet Couns 23(6):903\u2013909","journal-title":"J Genet Couns"},{"key":"597_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/jgc4.1988","author":"D Cragun","year":"2024","unstructured":"Cragun D et al (2024) Applying theories, models, and frameworks to help genetic counselors and students achieve clinical and professional goals. J Genet Couns. https:\/\/doi.org\/10.1002\/jgc4.1988","journal-title":"J Genet Couns"},{"issue":"6","key":"597_CR41","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s10897-007-9113-4","volume":"16","author":"PM Veach","year":"2007","unstructured":"Veach PM, Bartels DM, Leroy BS (2007) Coming full circle: a reciprocal-engagement model of genetic counseling practice. J Genet Couns 16(6):713\u2013728","journal-title":"J Genet Couns"},{"key":"597_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2023.1145879","volume":"14","author":"D Berrigan","year":"2023","unstructured":"Berrigan D et al (2023) Uncertainty: a neglected determinant of health behavior? Front Psychol 14:1145879","journal-title":"Front Psychol"},{"issue":"2","key":"597_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.pec.2020.07.017","volume":"104","author":"G Campbell-Salome","year":"2021","unstructured":"Campbell-Salome G et al (2021) Uncertainty management for individuals with Lynch syndrome: identifying and responding to healthcare barriers. Patient Educ Couns 104(2):403\u2013412","journal-title":"Patient Educ Couns"},{"issue":"1","key":"597_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13053-021-00201-1","volume":"19","author":"N den Elzen","year":"2021","unstructured":"den Elzen N et al (2021) \u201cLeft in limbo\u201d: exploring how patients with colorectal cancer interpret and respond to a suspected Lynch syndrome diagnosis. Hered Cancer Clin Pract 19(1):43","journal-title":"Hered Cancer Clin Pract"},{"key":"597_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780190270582.001.0001","volume-title":"Uncertainty in medicine: a framework for tolerance","author":"PKJ Han","year":"2021","unstructured":"Han PKJ (2021) Uncertainty in medicine: a framework for tolerance. Oxford University Press, New York, NY"},{"issue":"1","key":"597_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-statistics-010814-020148","volume":"4","author":"D Spiegelhalter","year":"2017","unstructured":"Spiegelhalter D (2017) Risk and uncertainty communication. Annu Rev Stat Appl 4(1):31\u201360","journal-title":"Annu Rev Stat Appl"},{"key":"597_CR47","first-page":"1","volume-title":"Encyclopedia of life sciences","author":"BB Biesecker","year":"2016","unstructured":"Biesecker BB (2016) Genetic counselling: psychological issues. Encyclopedia of life sciences. pp 1\u20135"},{"issue":"2","key":"597_CR48","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s10897-016-0023-1","volume":"26","author":"B Biesecker","year":"2017","unstructured":"Biesecker B, Austin J, Caleshu C (2017) Theories for psychotherapeutic genetic counseling: fuzzy trace theory and cognitive behavior theory. J Genet Couns 26(2):322\u2013330","journal-title":"J Genet Couns"},{"issue":"6","key":"597_CR49","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1177\/0272989X08327066","volume":"28","author":"VF Reyna","year":"2008","unstructured":"Reyna VF (2008) A theory of medical decision making and health: fuzzy trace theory. Med Decis Making 28(6):850\u2013865","journal-title":"Med Decis Making"},{"issue":"3","key":"597_CR50","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1017\/S1930297500002291","volume":"7","author":"VF Reyna","year":"2012","unstructured":"Reyna VF (2012) A new intuitionism: meaning, memory, and development in fuzzy-trace theory. J Judgment Decis Mak 7(3):332\u2013359","journal-title":"J Judgment Decis Mak"},{"issue":"9","key":"597_CR51","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1037\/0003-066X.58.9.697","volume":"58","author":"D Kahneman","year":"2003","unstructured":"Kahneman D (2003) A perspective on judgment and choice: mapping bounded rationality. Am Psychol 58(9):697\u2013720","journal-title":"Am Psychol"},{"issue":"4481","key":"597_CR52","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1126\/science.7455683","volume":"211","author":"A Tversky","year":"1981","unstructured":"Tversky A, Kahneman D (1981) The framing of decisions and the psychology of choice. Science 211(4481):453\u2013458","journal-title":"Science"},{"issue":"2","key":"597_CR53","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0010-0285(73)90033-9","volume":"5","author":"A Tversky","year":"1973","unstructured":"Tversky A, Kahneman D (1973) Availability: a heuristic for judging frequency and probability. Cognit Psychol 5(2):207\u2013232","journal-title":"Cognit Psychol"},{"key":"597_CR54","unstructured":"National Institute for Health and Care Excellence (2013) Clinical Guideline [CG164] Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer | Guidance | NICE. NICE."},{"key":"597_CR55","unstructured":"National Institute for Health and Care Excellence, [NG197] Shared decision making. 2021"},{"issue":"8","key":"597_CR56","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/gim.2016.212","volume":"19","author":"PKJ Han","year":"2017","unstructured":"Han PKJ et al (2017) A taxonomy of medical uncertainties in clinical genome sequencing. Genet Med 19(8):918\u2013925","journal-title":"Genet Med"},{"issue":"4","key":"597_CR57","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrg3463","volume":"14","author":"HL Rehm","year":"2013","unstructured":"Rehm HL (2013) Disease-targeted sequencing: a cornerstone in the clinic. Nat Rev Genet 14(4):295\u2013300","journal-title":"Nat Rev Genet"},{"issue":"19","key":"597_CR58","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","volume":"32","author":"AW Kurian","year":"2014","unstructured":"Kurian AW et al (2014) Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol 32(19):2001\u20132009","journal-title":"J Clin Oncol"},{"issue":"3","key":"597_CR59","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11523-021-00796-4","volume":"16","author":"L Cortesi","year":"2021","unstructured":"Cortesi L, Rugo HS, Jackisch C (2021) An overview of PARP inhibitors for the treatment of breast cancer. Target Oncol 16(3):255\u2013282","journal-title":"Target Oncol"},{"issue":"3","key":"597_CR60","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.annonc.2024.11.012","volume":"36","author":"T Andr\u00e9","year":"2025","unstructured":"Andr\u00e9 T et al (2025) Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study. Ann Oncol 36(3):277\u2013284","journal-title":"Ann Oncol"},{"issue":"7","key":"597_CR61","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/PAI.0000000000001212","volume":"32","author":"V Almeida","year":"2024","unstructured":"Almeida V et al (2024) Universal Lynch syndrome screening in colorectal cancer: a 5-year experience of a Portuguese pathology department. Appl Immunohistochem Mol Morphol 32(7):350\u2013356","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"8","key":"597_CR62","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/DCR.000000000000000","volume":"57","author":"FM Giardiello","year":"2014","unstructured":"Giardiello FM et al (2014) Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Dis Colon Rectum 57(8):1025\u20131048","journal-title":"Dis Colon Rectum"},{"key":"597_CR63","unstructured":"National Institute for Health and Care Excellence, [DG27] Molecular testing strategies for Lynch syndrome in people with colorectal cancer. 2017"},{"key":"597_CR64","unstructured":"National Institute for Health and Care Excellence, [DG42] Testing strategies for Lynch syndrome in people with endometrial cancer. 2020"},{"issue":"5","key":"597_CR65","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1053\/j.gastro.2022.08.058","volume":"164","author":"P Peltom\u00e4ki","year":"2023","unstructured":"Peltom\u00e4ki P et al (2023) Lynch syndrome genetics and clinical implications. Gastroenterology 164(5):783\u2013799","journal-title":"Gastroenterology"},{"issue":"11","key":"597_CR66","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","volume":"31","author":"F Mosele","year":"2020","unstructured":"Mosele F et al (2020) Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group. Ann Oncol 31(11):1491\u20131505","journal-title":"Ann Oncol"},{"issue":"2","key":"597_CR67","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/jamaoncol.2020.6252","volume":"7","author":"NJ Samadder","year":"2021","unstructured":"Samadder NJ et al (2021) Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol 7(2):230\u2013237","journal-title":"JAMA Oncol"},{"issue":"3","key":"597_CR68","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.annonc.2022.12.003","volume":"34","author":"Z Kuzbari","year":"2023","unstructured":"Kuzbari Z et al (2023) Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations. Ann Oncol 34(3):215\u2013227","journal-title":"Ann Oncol"},{"key":"597_CR69","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00328","author":"TP Slavin","year":"2018","unstructured":"Slavin TP et al (2018) Identification of incidental germline mutations in patients with advanced solid tumors who underwent cell-free circulating tumor DNA sequencing. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.18.00328","journal-title":"J Clin Oncol"},{"issue":"2","key":"597_CR70","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5694\/mja2.50356","volume":"212","author":"Y-J Kang","year":"2020","unstructured":"Kang Y-J et al (2020) The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome. Med J Aust 212(2):72\u201381","journal-title":"Med J Aust"},{"issue":"51","key":"597_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21510","volume":"21","author":"T Snowsill","year":"2017","unstructured":"Snowsill T et al (2017) Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation. Health Technol Assess 21(51):1\u2013238","journal-title":"Health Technol Assess"},{"issue":"1","key":"597_CR72","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/1940-6207.CAPR-10-0262","volume":"4","author":"TA Dinh","year":"2011","unstructured":"Dinh TA et al (2011) Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population. Cancer Prev Res (Phila) 4(1):9\u201322","journal-title":"Cancer Prev Res (Phila)"},{"issue":"9","key":"597_CR73","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/jmedgenet-2021-108062","volume":"59","author":"I Salikhanov","year":"2022","unstructured":"Salikhanov I et al (2022) Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives. J Med Genet 59(9):924\u2013930","journal-title":"J Med Genet"},{"issue":"8","key":"597_CR74","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41591-020-0982-5","volume":"26","author":"JJ Grzymski","year":"2020","unstructured":"Grzymski JJ et al (2020) Population genetic screening efficiently identifies carriers of autosomal dominant diseases. Nat Med 26(8):1235\u20131239","journal-title":"Nat Med"},{"key":"597_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2025.101659","author":"T Pal","year":"2026","unstructured":"Pal T et al (2026) Consideration of inherited cancer risk on a continuum: an international and multidisciplinary perspective: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. https:\/\/doi.org\/10.1016\/j.gim.2025.101659","journal-title":"Genet Med"},{"issue":"1","key":"597_CR76","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1038\/s41598-020-60149-5","volume":"10","author":"M Rumford","year":"2020","unstructured":"Rumford M et al (2020) Oncologist-led BRCA \u201cmainstreaming\u201d in the ovarian cancer clinic: a study of 255 patients and its impact on their management. Sci Rep 10(1):3390","journal-title":"Sci Rep"},{"key":"597_CR77","doi-asserted-by":"publisher","first-page":"1140135","DOI":"10.3389\/fonc.2023.1140135","volume":"13","author":"R O'Shea","year":"2023","unstructured":"O\u2019Shea R et al (2023) A mainstreaming oncogenomics model: improving the identification of Lynch syndrome. Front Oncol 13:1140135","journal-title":"Front Oncol"},{"issue":"1","key":"597_CR78","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ygyno.2017.01.030","volume":"145","author":"M Kentwell","year":"2017","unstructured":"Kentwell M et al (2017) Mainstreaming cancer genetics: A model integrating germline <em>BRCA<\/em> testing into routine ovarian cancer clinics. Gynecol Oncol 145(1):130\u2013136","journal-title":"Gynecol Oncol"},{"key":"597_CR79","unstructured":"National Genomics Education Programme. GeNotes. no date 16\/09\/2024]; Available from: https:\/\/www.genomicseducation.hee.nhs.uk\/genotes\/."},{"key":"597_CR80","doi-asserted-by":"crossref","unstructured":"Zimani AN, Peterlin B, Kovanda A (2021) Increasing genomic literacy through national genomic projects. Front Genet 12","DOI":"10.3389\/fgene.2021.693253"},{"issue":"3","key":"597_CR81","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1001\/jamainternmed.2017.8049","volume":"178","author":"BB Biesecker","year":"2018","unstructured":"Biesecker BB et al (2018) Web platform vs in-person genetic counselor for return of carrier results from exome sequencing a randomized clinical trial. JAMA Intern Med 178(3):338\u2013346","journal-title":"JAMA Intern Med"},{"issue":"1","key":"597_CR82","doi-asserted-by":"publisher","DOI":"10.1136\/bmjhci-2023-100809","volume":"30","author":"J Zhang","year":"2023","unstructured":"Zhang J et al (2023) Quantifying digital health inequality across a national healthcare system. BMJ Health Care Inform 30(1):e100809","journal-title":"BMJ Health Care Inform"},{"issue":"6","key":"597_CR83","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s41436-021-01112-1","volume":"23","author":"S Shickh","year":"2021","unstructured":"Shickh S et al (2021) The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care. Genet Med 23(6):1086\u20131094","journal-title":"Genet Med"},{"key":"597_CR84","doi-asserted-by":"crossref","unstructured":"Torr B et al. (2024) BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial. Br J Cancer","DOI":"10.1101\/2024.05.03.24306669"},{"issue":"4 Suppl 2","key":"597_CR85","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.apmr.2003.08.109","volume":"85","author":"GW White","year":"2004","unstructured":"White GW, Suchowierska M, Campbell M (2004) Developing and systematically implementing participatory action research. Arch Phys Med Rehabil 85(4 Suppl 2):S3-12","journal-title":"Arch Phys Med Rehabil"},{"key":"597_CR86","unstructured":"NHS England, National Cancer Plan for England: delivering world class cancer care, D.o.H.a.S. Care, Editor. 2026."},{"issue":"Suppl 2","key":"597_CR87","first-page":"A204","volume":"72","author":"K Monahan","year":"2023","unstructured":"Monahan K et al (2023) P293 Finding the missing 95%: the English national Lynch syndrome transformation project. Gut 72(Suppl 2):A204\u2013A204","journal-title":"Gut"},{"issue":"9","key":"597_CR88","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1111\/codi.16707","volume":"25","author":"L Monje-Garcia","year":"2023","unstructured":"Monje-Garcia L et al (2023) From diagnosis of colorectal cancer to diagnosis of Lynch syndrome: the RM Partners quality improvement project. Colorectal Dis 25(9):1844\u20131851","journal-title":"Colorectal Dis"},{"issue":"5","key":"597_CR89","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41431-024-01550-w","volume":"32","author":"FE McRonald","year":"2024","unstructured":"McRonald FE et al (2024) Identification of people with Lynch syndrome from those presenting with colorectal cancer in England: baseline analysis of the diagnostic pathway. Eur J Hum Genet 32(5):529\u2013538","journal-title":"Eur J Hum Genet"},{"key":"597_CR90","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2024-110231","author":"L Loong","year":"2024","unstructured":"Loong L et al (2024) Lynch syndrome diagnostic testing pathways in endometrial cancers: a nationwide English registry-based study. J Med Genet. https:\/\/doi.org\/10.1136\/jmg-2024-110231","journal-title":"J Med Genet"},{"key":"597_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102465","volume":"69","author":"C Huntley","year":"2024","unstructured":"Huntley C et al (2024) The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data resource. EClinicalMedicine 69:102465","journal-title":"EClinicalMedicine"},{"issue":"2","key":"597_CR92","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1200\/JCO.2014.58.1322","volume":"33","author":"EM Stoffel","year":"2015","unstructured":"Stoffel EM et al (2015) Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol 33(2):209\u2013217","journal-title":"J Clin Oncol"},{"key":"597_CR93","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1200\/EDBK_208341","volume":"38","author":"MB Yurgelun","year":"2018","unstructured":"Yurgelun MB, Hampel H (2018) Recent advances in Lynch syndrome: diagnosis, treatment, and cancer prevention. Am Soc Clin Oncol Educ Book 38:101\u2013109","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"9","key":"597_CR94","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s41436-020-0825-2","volume":"22","author":"N Dragojlovic","year":"2020","unstructured":"Dragojlovic N et al (2020) The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review. Genet Med 22(9):1437\u20131449","journal-title":"Genet Med"},{"key":"597_CR95","unstructured":"NHS England. NHS Genomic Medicine Service. 2021 27\/07\/2021]; Available from: https:\/\/www.england.nhs.uk\/genomics\/nhs-genomic-med-service\/."},{"issue":"3","key":"597_CR96","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10549-016-3964-z","volume":"159","author":"SA Cohen","year":"2016","unstructured":"Cohen SA, Nixon DM (2016) A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital. Breast Cancer Res Treat 159(3):527\u2013534","journal-title":"Breast Cancer Res Treat"},{"key":"597_CR97","doi-asserted-by":"crossref","unstructured":"Esplen MJ, Kohut K (2025) Bridging the gap: the need to integrate psychosocial oncology services into cancer genetics. J Psychosoc Oncol Res Pract 7(1)","DOI":"10.1097\/OR9.0000000000000155"},{"issue":"7","key":"597_CR98","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/jmedgenet-2015-103740","volume":"53","author":"R Manchanda","year":"2016","unstructured":"Manchanda R et al (2016) Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1\/2 mutations. J Med Genet 53(7):472\u2013480","journal-title":"J Med Genet"},{"issue":"3","key":"597_CR99","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/1471-0528.15905","volume":"127","author":"R Manchanda","year":"2020","unstructured":"Manchanda R et al (2020) Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes. BJOG 127(3):364\u2013375","journal-title":"BJOG"},{"key":"597_CR100","doi-asserted-by":"publisher","first-page":"1075076","DOI":"10.3389\/fpubh.2023.1075076","volume":"11","author":"S Jaskulski","year":"2023","unstructured":"Jaskulski S, Nuszbaum C, Michels KB (2023) Components, prospects and challenges of personalized prevention. Front Public Health 11:1075076","journal-title":"Front Public Health"},{"issue":"12","key":"597_CR101","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/s41416-024-02733-4","volume":"130","author":"O Tsoulaki","year":"2024","unstructured":"Tsoulaki O et al (2024) Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practice. Br J Cancer 130(12):2027\u20132036","journal-title":"Br J Cancer"},{"issue":"5","key":"597_CR102","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424","journal-title":"Genet Med"},{"key":"597_CR103","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2025-110979","author":"J Christopher","year":"2025","unstructured":"Christopher J et al (2025) Recontact and follow-up for individuals with germline pathogenic variants in hereditary breast and ovarian cancer susceptibility genes: a UK Cancer Genetics Group consensus meeting. J Med Genet. https:\/\/doi.org\/10.1136\/jmg-2025-110979","journal-title":"J Med Genet"},{"issue":"2","key":"597_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101305","volume":"27","author":"A Garrett","year":"2025","unstructured":"Garrett A et al (2025) Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: framework for genetics clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK). Genet Med 27(2):101305","journal-title":"Genet Med"},{"issue":"11","key":"597_CR105","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1016\/j.pec.2021.09.001","volume":"104","author":"PKJ Han","year":"2021","unstructured":"Han PKJ (2021) Medical uncertainty: putting flesh on the bones. Patient Educ Couns 104(11):2603\u20132605","journal-title":"Patient Educ Couns"},{"issue":"3","key":"597_CR106","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1460-2466.2001.tb02892.x","volume":"51","author":"DE Brashers","year":"2001","unstructured":"Brashers DE (2001) Communication and uncertainty management. J Commun 51(3):477\u2013497","journal-title":"J Commun"},{"issue":"5","key":"597_CR107","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41431-020-00799-1","volume":"29","author":"NM Medendorp","year":"2021","unstructured":"Medendorp NM et al (2021) A randomized experimental study to test the effects of discussing uncertainty during cancer genetic counseling: different strategies, different outcomes? Eur J Hum Genet 29(5):789\u2013799","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"597_CR108","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.pec.2021.07.004","volume":"105","author":"CE Napier","year":"2022","unstructured":"Napier CE et al (2022) Cancer patient knowledge about and behavioral intentions after germline genome sequencing. Patient Educ Couns 105(3):707\u2013718","journal-title":"Patient Educ Couns"},{"issue":"9","key":"597_CR109","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/s41436-020-0829-y","volume":"22","author":"N Bartley","year":"2020","unstructured":"Bartley N et al (2020) Patient experience of uncertainty in cancer genomics: a systematic review. Genet Med 22(9):1450\u20131460","journal-title":"Genet Med"},{"issue":"4","key":"597_CR110","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin AR et al (2019) Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet 51(4):584\u2013591","journal-title":"Nat Genet"},{"issue":"3","key":"597_CR111","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/jgc4.1246","volume":"29","author":"M Rosenbaum","year":"2020","unstructured":"Rosenbaum M et al (2020) Interpreters\u2019 perceptions of culture bumps in genetic counseling. J Genet Couns 29(3):352\u2013364","journal-title":"J Genet Couns"},{"issue":"1","key":"597_CR112","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pec.2014.03.014","volume":"96","author":"SA Flocke","year":"2014","unstructured":"Flocke SA et al (2014) Teachable moments for health behavior change and intermediate patient outcomes. Patient Educ Couns 96(1):43\u201349","journal-title":"Patient Educ Couns"},{"issue":"6","key":"597_CR113","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1007\/s00520-022-06974-y","volume":"30","author":"M Morand","year":"2022","unstructured":"Morand M et al (2022) Factors impacting adolescent and young adult cancer patients\u2019 decision to pursue genetic counseling and testing. Support Care Cancer 30(6):5481\u20135489","journal-title":"Support Care Cancer"},{"issue":"3","key":"597_CR114","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/jgc4.1386","volume":"30","author":"MLB Schwartz","year":"2021","unstructured":"Schwartz MLB et al (2021) Genetic counseling for patients with positive genomic screening results: considerations for when the genetic test comes first. J Genet Couns 30(3):634\u2013644","journal-title":"J Genet Couns"},{"key":"597_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192114098","author":"C Diez de Los Rios de la Serna","year":"2022","unstructured":"Diez de Los Rios de la Serna C, Fern\u00e1ndez-Ortega P, Lluch-Canut T (2022) Lifestyle behavior interventions for preventing cancer in adults with inherited cancer syndromes: systematic review. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph192114098","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"597_CR116","doi-asserted-by":"publisher","first-page":"e2131455","DOI":"10.1001\/jamanetworkopen.2021.31455","volume":"4","author":"GB Taksler","year":"2021","unstructured":"Taksler GB et al (2021) Effect of individualized preventive care recommendations vs usual care on patient interest and use of recommendations: a pilot randomized clinical trial. JAMA Netw Open 4(11):e2131455\u2013e2131455","journal-title":"JAMA Netw Open"},{"issue":"2","key":"597_CR117","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10897-005-4067-x","volume":"14","author":"J Hodgson","year":"2005","unstructured":"Hodgson J, Spriggs M (2005) A practical account of autonomy: why genetic counseling is especially well suited to the facilitation of informed autonomous decision making. J Genet Couns 14(2):89\u201397","journal-title":"J Genet Couns"},{"issue":"12","key":"597_CR118","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/s41431-022-01199-3","volume":"30","author":"J Hastings Ward","year":"2022","unstructured":"Hastings Ward J et al (2022) Research participants: critical friends, agents for change. Eur J Hum Genet 30(12):1309\u20131313","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"597_CR119","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/pon.6141","volume":"32","author":"E Lima","year":"2023","unstructured":"Lima E et al (2023) Communication about hereditary cancer risk to offspring: a systematic review of children\u2019s perspective. Psychooncology 32(6):875\u2013887","journal-title":"Psychooncology"},{"key":"597_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081577","author":"LJ Lindberg","year":"2024","unstructured":"Lindberg LJ et al (2024) National experiences from 30 years of provider-mediated cascade testing in Lynch syndrome families-the Danish model. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16081577","journal-title":"Cancers (Basel)"},{"key":"597_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184485","author":"V Baroutsou","year":"2023","unstructured":"Baroutsou V et al (2023) Acceptability and usability of the Family Gene Toolkit for Swiss and Korean families harboring BRCA1\/BRAC2 pathogenic variants: a web-based platform for cascade genetic testing. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15184485","journal-title":"Cancers (Basel)"},{"issue":"1","key":"597_CR122","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1158\/1940-6207.CAPR-23-0303","volume":"17","author":"EM Bednar","year":"2024","unstructured":"Bednar EM et al (2024) Experiences of family communication and cascade genetic testing for hereditary cancer in medically underserved populations-a qualitative study. Cancer Prev Res (Phila) 17(1):19\u201328","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"597_CR123","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41431-022-01200-z","volume":"31","author":"AL Young","year":"2023","unstructured":"Young AL et al (2023) Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review. Eur J Hum Genet 31(1):18\u201334","journal-title":"Eur J Hum Genet"},{"key":"597_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11090850","author":"RM Hendricks-Sturrup","year":"2021","unstructured":"Hendricks-Sturrup RM, Joseph L, Lu CY (2021) Patient-reported outcomes following genetic testing for familial hypercholesterolemia, breast and ovarian cancer syndrome, and Lynch syndrome: a systematic review. J Pers Med. https:\/\/doi.org\/10.3390\/jpm11090850","journal-title":"J Pers Med"},{"issue":"2","key":"597_CR125","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10689-013-9653-8","volume":"12","author":"EM Bleiker","year":"2013","unstructured":"Bleiker EM et al (2013) 100 years Lynch syndrome: what have we learned about psychosocial issues? Fam Cancer 12(2):325\u2013339","journal-title":"Fam Cancer"},{"key":"597_CR126","unstructured":"European Medicines Agency (2026) Reflection paper on patient experience data"},{"key":"597_CR127","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1399-0004.2011.01636.x","volume":"79","author":"M McAllister","year":"2011","unstructured":"McAllister M et al (2011) The Genetic Counseling Outcome Scale: a new patient-reported outcome measure for clinical genetics services. Clin Genet 79:413\u2013424","journal-title":"Clin Genet"},{"issue":"5","key":"597_CR128","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ejmg.2018.11.015","volume":"62","author":"PE Grant","year":"2019","unstructured":"Grant PE et al (2019) Developing a short-form of the Genetic Counselling Outcome Scale: the Genomics Outcome Scale. Eur J Med Genet 62(5):324\u2013334","journal-title":"Eur J Med Genet"},{"issue":"8","key":"597_CR129","doi-asserted-by":"publisher","first-page":"e2424793","DOI":"10.1001\/jamanetworkopen.2024.24793","volume":"7","author":"AK Balitsky","year":"2024","unstructured":"Balitsky AK et al (2024) Patient-reported outcome measures in cancer care: an updated systematic review and meta-analysis. JAMA Netw Open 7(8):e2424793\u2013e2424793","journal-title":"JAMA Netw Open"},{"key":"597_CR130","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j3453","volume":"358","author":"S Staniszewska","year":"2017","unstructured":"Staniszewska S et al (2017) GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. BMJ 358:j3453","journal-title":"BMJ"},{"issue":"9","key":"597_CR131","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.pec.2017.03.013","volume":"100","author":"M Dean","year":"2017","unstructured":"Dean M et al (2017) \u201cWhen information is not enough\u201d: a model for understanding BRCA-positive previvors\u2019 information needs regarding hereditary breast and ovarian cancer risk. Patient Educ Couns 100(9):1738\u20131743","journal-title":"Patient Educ Couns"},{"key":"597_CR132","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1057\/s41292-019-00154-8","volume":"15","author":"AA Ross Arguedas","year":"2019","unstructured":"Ross Arguedas AA et al (2019) Intersections of health and gender imperatives: stratified decision-making among women with a BRCA mutation. BioSocieties 15:245\u2013269","journal-title":"BioSocieties"},{"issue":"4","key":"597_CR133","doi-asserted-by":"publisher","first-page":"329.e1","DOI":"10.1016\/j.ajog.2013.01.026","volume":"208","author":"K Singh","year":"2013","unstructured":"Singh K et al (2013) Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers. Am J Obstet Gynecol 208(4):329.e1-329.e6","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"597_CR134","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1080\/10810730.2017.1373875","volume":"22","author":"EA Rauscher","year":"2017","unstructured":"Rauscher EA (2017) Investigating uncertainty in genetic counseling encounters: managing information about genetic cancer risk. J Health Commun 22(11):896\u2013904","journal-title":"J Health Commun"},{"issue":"2","key":"597_CR135","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/10410236.2016.1250187","volume":"33","author":"M Dean","year":"2018","unstructured":"Dean M, Davidson LG (2018) Previvors\u2019 uncertainty management strategies for hereditary breast and ovarian cancer. Health Commun 33(2):122\u2013130","journal-title":"Health Commun"},{"key":"597_CR136","unstructured":"Vicari SD, Guo H (2026) Social media for carriers of hereditary cancer syndromes. Final report from the project Previvorship in the Platform Society: Cancer Genetic Risk in the Digital Age"},{"key":"597_CR137","doi-asserted-by":"publisher","DOI":"10.1177\/1461444820926632","author":"S Vicari","year":"2021","unstructured":"Vicari S (2021) Is it all about storytelling? Living and learning hereditary cancer on Twitter. New Media Soc. https:\/\/doi.org\/10.1177\/1461444820926632","journal-title":"New Media Soc"},{"issue":"1","key":"597_CR138","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9566.13846","volume":"47","author":"S Vicari","year":"2025","unstructured":"Vicari S, Ditchfield H, Chuang Y (2025) Contemporary visualities of ill health: on the social (media) construction of disease regimes. Sociol Health Illn 47(1):e13846","journal-title":"Sociol Health Illn"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00597-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-026-00597-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00597-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:02:49Z","timestamp":1788001369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-026-00597-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":138,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["597"],"URL":"https:\/\/doi.org\/10.1007\/s10689-026-00597-6","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. Patient narratives were written by patient co-authors in their own words. This was not part of a research study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"84"}}